Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
5-[1-[4-(2-Chloroethoxy)phenyl]-2-phenyl-1-buten-1-yl]-1,3-benzodioxole is a metabolite of Tamoxifen (T006000), a selective estrogen response modifier, protein kinase C inhibitor and anti-angiogenetic factor.